在重症医学会/欧洲重症医学会联合数据科学合作下负责任地共享ICU患者数据:阿姆斯特丹大学医学中心数据库(AmsterdamUMCdb)范例
重症监护医学因ICU入院产生海量数据而成为机器学习改善危重患者结局的天然环境,但技术、法律、伦理和隐私顾虑限制了数据共享。重症医学会与欧洲重症医学会将ICU患者数据共享列为联合数据科学合作的优先事项之一。作者描述AmsterdamUMCdb的开发与发布,该库采用基于风险的去识别策略,并实施合同与治理流程及沟通策略,患者组织、支持医院及伦理与隐私专家对其流程和数据库进行了审计。该库包含2003至2016年入院ICU患者的约10亿临床数据点,来自23,106次入住、20,109例患者;隐私审计结论为重新识别不具合理可能性,在美国《健康保险携带和责任法案》和欧洲《通用数据保护条例》背景下均可视为匿名信息;伦理审计结论为负责任的数据共享负担极小、潜在获益巨大。
要点
- AmsterdamUMCdb含约10亿临床数据点,来自23,106次入住、20,109例患者,数据年份为2003至2016年。
- 隐私审计结论:重新识别不具合理可能性,在美国《健康保险携带和责任法案》和欧洲《通用数据保护条例》背景下均可视为匿名信息。
- 伦理审计结论:负责任的数据共享负担极小,潜在获益巨大。
- 采用基于风险的去识别策略以兼顾数据效用与隐私,并实施合同与治理流程及沟通策略。
- 技术、法律、伦理和隐私挑战可通过多学科方法解决;基于风险的去识别策略符合美欧隐私法规,作者认为应作为发布ICU患者数据的首选方法。
适用人群与场景
- 2003年至2016年间入住大学医院ICU的患者数据,共23,106次入住、20,109例患者。
处置流程与药物剂量
- 采用基于风险的去识别策略,在维护数据效用的同时保护隐私。
- 实施合同与治理流程及沟通策略。
- 患者组织、支持医院及伦理与隐私专家对上述流程和数据库进行审计。
研究设计与关键结果
- AmsterdamUMCdb包含约10亿临床数据点,来自23,106次入住、20,109例患者,数据年份为2003至2016年。
- 隐私审计结论为重新识别不具合理可能性,在美国《健康保险携带和责任法案》和欧洲《通用数据保护条例》背景下均可视为匿名信息。
- 伦理审计结论为负责任的数据共享负担极小,潜在获益巨大。
证据类型、等级与局限
- 证据类型:数据库开发与发布描述及审计报告。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基于风险的去识别策略符合美国和欧洲隐私法规,应作为发布ICU患者数据的首选方法。
- 作者认为,技术、法律、伦理和隐私挑战可通过多学科方法解决,以支持重症医学会与欧洲重症医学会通过大规模合并ICU数据集进行科学探究来改善重症监护结局的共同愿景。
指南或共识出处
- 重症医学会与欧洲重症医学会联合数据科学合作。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Critical care medicine is a natural environment for machine learning approaches to improve outcomes for critically ill patients as admissions to ICUs generate vast amounts of data. However, technical, legal, ethical, and privacy concerns have so far limited the critical care medicine community from making these data readily available. The Society of Critical Care Medicine and the European Society of Intensive Care Medicine have identified ICU patient data sharing as one of the priorities under their Joint Data Science Collaboration. To encourage ICUs worldwide to share their patient data responsibly, we now describe the development and release of Amsterdam University Medical Centers Database (AmsterdamUMCdb), the first freely available critical care database in full compliance with privacy laws from both the United States and Europe, as an example of the feasibility of sharing complex critical care data.
SETTING: University hospital ICU.
SUBJECTS: Data from ICU patients admitted between 2003 and 2016.
INTERVENTIONS: We used a risk-based deidentification strategy to maintain data utility while preserving privacy. In addition, we implemented contractual and governance processes, and a communication strategy. Patient organizations, supporting hospitals, and experts on ethics and privacy audited these processes and the database.
MEASUREMENTS AND MAIN RESULTS: AmsterdamUMCdb contains approximately 1 billion clinical data points from 23,106 admissions of 20,109 patients. The privacy audit concluded that reidentification is not reasonably likely, and AmsterdamUMCdb can therefore be considered as anonymous information, both in the context of the U.S. Health Insurance Portability and Accountability Act and the European General Data Protection Regulation. The ethics audit concluded that responsible data sharing imposes minimal burden, whereas the potential benefit is tremendous.
CONCLUSIONS: Technical, legal, ethical, and privacy challenges related to responsible data sharing can be addressed using a multidisciplinary approach. A risk-based deidentification strategy, that complies with both U.S. and European privacy regulations, should be the preferred approach to releasing ICU patient data. This supports the shared Society of Critical Care Medicine and European Society of Intensive Care Medicine vision to improve critical care outcomes through scientific inquiry of vast and combined ICU datasets.
参考来源
- Thoral PJ, Peppink JM, Driessen RH, et al. Sharing ICU Patient Data Responsibly Under the Society of Critical Care Medicine/European Society of Intensive Care Medicine Joint Data Science Collaboration: The Amsterdam University Medical Centers Database (AmsterdamUMCdb) Example. Crit Care Med. 2021. PMID: 33625129. doi:10.1097/CCM.0000000000004916
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。